Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...
Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback